Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Rectal Neoplasm With Metastasis to the Liver”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00033748
What this trial is testing

Vaccine Therapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Alliance for Clinical Trials in Oncology 56
Large-scale testing (Phase 3)UnknownNCT00002692
What this trial is testing

Intravenous Compared With Intrahepatic Chemotherapy in Treating Patients With Colorectal Cancer Metastatic to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Medical Research Council 312
Testing effectiveness (Phase 2)Looking for participantsNCT06607458
What this trial is testing

Evaluation of the Safety and Efficacy of Treatment w/High Dose Melphalan Given Directly Into the Liver Followed by Treatment w/Approved Cancer Treatment or Approved Cancer Treatment Alone in Patients w/ Metastatic Colorectal Cancer w/Liver Dominant Disease

Who this might be right for
Refractory Metastatic Colorectal Cancer
Delcath Systems Inc. 90
Testing effectiveness (Phase 2)Study completedNCT02380443
What this trial is testing

AlloStim® Immunotherapy Dosing Alone or in Combination With Cryoablation in Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer Metastatic
Mirror Biologics, Inc. 13
Testing effectiveness (Phase 2)Looking for participantsNCT05954429
What this trial is testing

Explore the Third-line Treatment of Fruquintinib Combined With Serplulimab in Advanced Non-liver-limited Metastatic Colorectal Cancer: a Single-center, Phase 2 Study

Who this might be right for
Colorectal Cancer
Fudan University 50
Early research (Phase 1)Study completedNCT00496509
What this trial is testing

Phase I Efficacy On Vascular Permeability In Patients With Advanced Colorectal Cancer

Who this might be right for
Colorectal Cancer
Genzyme, a Sanofi Company 24
Early research (Phase 1)Ended earlyNCT02559024
What this trial is testing

Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Neoplasms
Providence Health & Services 4
Not applicableUnknownNCT04213222
What this trial is testing

Radiomics Assess of Bevacizumab Plus Chemo in Colorectal Cancer Liver Metastases

Who this might be right for
Colon CancerRectal CancerLiver Metastases
Peking University People's Hospital 300
Large-scale testing (Phase 3)Study completedNCT00440310
What this trial is testing

Phase 3 Trial of Litx™ Plus Chemotherapy vs. Chemotherapy Only Treating Colorectal Cancer Patients With Recurrent Liver Metastases

Who this might be right for
Liver MetastasesColorectal NeoplasmsNeoplasm Metastasis+1 more
Light Sciences Oncology 483
Not applicableStudy completedNCT00677586
What this trial is testing

Simultaneous Versus Staged Resection for Initially Resectable Synchronous Rectal Cancer Liver-limited Metastasis

Who this might be right for
Rectal Neoplasm With Metastasis to the Liver
Fudan University 180
Post-approval studies (Phase 4)Ended earlyNCT04973007
What this trial is testing

Comparison of Contrast Agents in Liver Magnetic Resonance (MR) for the Detection of Hepatic Metastases

Who this might be right for
Oligometastatic DiseaseLiver MetastasesColorectal Cancer
University of Colorado, Denver 10
Testing effectiveness (Phase 2)Study completedNCT00089401
What this trial is testing

Isolated Hepatic Perfusion With Melphalan in Treating Patients With Unresectable Colorectal Cancer That Has Metastasized to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
National Institutes of Health Clinical Center (CC) 8
Large-scale testing (Phase 3)Looking for participantsNCT02885753
What this trial is testing

Systemic Oxaliplatin or Intra-arterial Chemotherapy Combined With LV5FU2 +/- Irinotecan and an Target Therapy in First Line Treatment of Metastatic Colorectal Cancer Restricted to the Liver

Who this might be right for
Colorectal Neoplasms
Federation Francophone de Cancerologie Digestive 348
Large-scale testing (Phase 3)UnknownNCT03125161
What this trial is testing

Study Comparing HAI Plus Chemotherapy and Chemotherapy Alone in Patients With Unresectable CRLM

Who this might be right for
Colorectal Adenocarcinoma Metastatic to the Liver
Fudan University 150
Testing effectiveness (Phase 2)Ended earlyNCT01320683
What this trial is testing

Combination Chemotherapy and Bevacizumab Before Surgery and Radiolabeled Monoclonal Antibody Therapy in Treating Liver Metastases in Patients With Metastatic Colorectal Cancer

Who this might be right for
Liver MetastasesRecurrent Colon CancerRecurrent Rectal Cancer+4 more
City of Hope Medical Center 1
Not applicableStudy completedNCT04866290
What this trial is testing

HepaSphere™ Microspheres Prospective Registry

Who this might be right for
Metastatic Colorectal Cancer
Merit Medical Systems, Inc. 105
Not applicableStudy completedNCT00984048
What this trial is testing

Study to Identify Mechanisms of Resistance to Standard Therapy in Patients With Metastatic Colorectal Cancer

Who this might be right for
Colorectal Cancer
Jewish General Hospital 160
Early research (Phase 1)Study completedNCT00012155
What this trial is testing

Gene Therapy in Treating Patients With Colon Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center
Testing effectiveness (Phase 2)Looking for participantsNCT06362369
What this trial is testing

Oral 7HP349 (Alintegimod) in Combination With Ipilimumab Followed by Nivolumab Monotherapy

Who this might be right for
Advanced CancerAdvanced Solid TumorMelanoma+15 more
7 Hills Pharma, LLC 126
Testing effectiveness (Phase 2)Active Not RecruitingNCT00492999
What this trial is testing

Hepatic Arterial Infusion With Floxuridine and Dexamethasone Combined With Combination Chemotherapy in Treating Patients With Colorectal Cancer That Has Spread to the Liver

Who this might be right for
Colorectal CancerMetastatic Cancer
Memorial Sloan Kettering Cancer Center 64
Next Page